Background. BALB/c mice control infection with the obligate intracellular parasite Toxoplasma gondii and develop a latent chronic infection in the brain, as do immunocompetent humans. Interferon-␥-producing CD8 ϩ T cells provide essential protection against T. gondii infection, but the epitopes recognized have so far remained elusive.
Toxoplasma gondii is an obligate intracellular parasite infecting all homeothermic vertebrate hosts, with human infection rates of 20%-90%. As the causative agent of toxoplasmic encephalitis, the parasite poses a severe health threat for immunocompromised individuals, especially AIDS patients, and it causes congenital defects in newborns [1] . No human vaccines or drugs that eradicate the infection are available.
In humans and rodents, T. gondii exists as the rapidly multiplying lytic tachyzoites, which later during infection convert into slower growing bradyzoites, harbored in cysts in neural and muscular tissue [2] . Sequential secretion through 3 organelles-micronemes, rhoptries, and dense granules from tachyzoites-mediates invasion and survival inside the host cell [3] . In Europe and North America the prevalent T. gondii strains are divided into 3 types, with type II strains accounting for Ͼ70% of isolates obtained from human cases of toxoplasmosis [4] .
Like immunocompetent humans [5] , BALB/c mice limit type II and III T. gondii, with fewer cysts in their brains developing a latent chronic infection, compared with susceptible mouse strains [6] . This is ascribed to the generation of H-2L d -restricted cytotoxic T lymphocytes and dependent on type II parasites [7] . When the immune response wanes, the parasite may recrudesce from the bradyzoite to the tachyzoite stage, which can invade virtually any nucleated cell. By replicating unchecked, T. gondii can cause fatal toxoplasmic encephalitis. The generation of interferon (IFN)-␥ by innate NK cells and by CD4 ϩ and CD8 ϩ T lymphocytes is central to host resistance [8 -10] ; however, no T. gondii-derived CD8 ϩ T cell epitopes have been reported to date. Published re-ports of T. gondii-specific CD8 ϩ T cell responses are based on studies in which animals were vaccinated mostly with major parasite protein: the surface antigens (SAG1-SAG3). The resulting CD8 ϩ T cells responded to either parasite lysate or to peptide restimulation in vitro ( [11] [12] [13] [14] and references therein). Whether these potential SAG epitopes are generated in the course of a natural infection is not known. Problems inherent in the identification of parasite-derived T cell epitopes are the organisms' large and complex genomes, their multifaceted life cycles, and their persistence in the host despite the presence of protective immunity. We used the caged major histocompatibility complex (MHC)-tetramer technology [15] [16] [17] to generate an array of ϳ250 H-2L d tetramers of defined specificity to screen for T. gondii-specific T cell epitopes in infected BALB/c mice. We identified CD8 ϩ T cell epitopes derived from 2 distinct parasite proteins, dense granule protein GRA4 and rhoptry protein ROP7. The GRA4-specific T cells are detected during the acute phase of the infection, whereas the T cells reactive to the ROP7 peptide persist during the chronic phase. Both types of T cells secrete protective IFN-␥. Mice infected with mutant parasites defective in establishing a chronic infection exhibit altered levels of the 2 epitope-reactive T cells throughout the course of infection, consistent with the ability of bradyzoites to sustain a ROP7-reactive CD8 ϩ T cell response. The identification of endogenous T. gondii-derived epitopes, as distinct from the use of engineered T. gondii expressing model antigens, affords new opportunities for dissecting the immune response against the parasite.
MATERIALS AND METHODS
Antibodies and parasite strains. J.F. Dubremetz provided ROP7 antibody T 4 3H 1 [18] , D. Sibley provided the GRA4 antibody [19] , J. Saeij provided the SAG2Y antibody [20] , and J. Gaertig provided the 12G10 anti-tubulin antibody. T. gondii Pru ⌬HXGPRT and ME49 tachyzoites were propagated in human foreskin fibroblast (HFF) monolayers grown in Dulbecco's modified Eagle medium containing 10% fetal calf serum and penicillin-streptomycin. The 73F9 and 9xG4 mutants were previously isolated [21] . The mutant 76-E2 is described in the appendix, which is not available in the print version.
Experimental animals and T. gondii infection. All animal protocols were approved by the Massachusetts Institute of Technology (MIT) Committee on Animal Care. Swiss-Webster and BALB/c mice were obtained from Taconic. Forty cysts of the T. gondii ME49 strain (a gift from G. Yap) were isolated from the brain homogenate of an infected Swiss-Webster animal and injected intraperitoneally into BALB/c animals for future analysis of the T cell response. Alternatively, BALB/c mice were infected with 5000 Prugniaud tachyzoites or 2 ϫ 10 6 ␥-irradiated Prugniaud tachyzoites (15 kRad).
Composition of the Toxoplasma secretome gene list For the generation of the list of 73 T. gondii target proteins see the appendix, which is not available in the print version.
H-2L d epitope prediction
The 73 selected open reading frames (ORFs) (table A1, which is available only as a pdf in the electronic version) were analyzed by use of the Web-based predictive algorithms BIMAS [22] , RANKPEP [23] , and SYFPEITHI [24] and predicted 9 amino acid residue epitopes that scored higher then 150, 92, and 21, respectively, were incorporated into the screen. Double hits were removed, yielding 246 unique nonameric sequences.
Peptide synthesis. Conditional ligands p29-P6* to p29-P8* were constructed manually, using 9-flourenylmethloxycarbonyl -based solid-phase peptide synthesis. The MIT Center for Cancer Research biopolymers facility (Cambridge, Massachusetts) synthesized the peptides used for screening.
Protein expression and purification. Recombinant expression of murine ␤ 2 m, as well as the luminal portion of the H-2L d heavy chain with a C-terminal BirA recognition sequence (plasmid gift of J. D. Altman), was accomplished by following established protocols. Refolding of the MHC complex with conditional ligands p29-P6* to p29-P8* was followed by biotinylation, size-exclusion chromatography (S75) [25] , and assembled monomers were stored at Ϫ80°C. Class I MHC tetramers [26] were produced by addition of streptavidin-phycoerythrin (Invitrogen) to monomer at a final molar ratio of 4:1, respectively, and peptide exchange was effected by irradiation at 365 nm (Stratalinker 2400 UV), as described elsewhere [16] .
Cell preparation and tetramer staining. The peritoneal cavity of BALB/c mice was lavaged, and splenocytes and mononucleated cells from the brain were prepared. For screening, CD8 ϩ T cells were isolated with a Milteny Biotech kit. To purify brain T cells, the mice were perfused intracardially with PBS and the brain homogenized and passed over a 35% Percoll solution, followed by a 70%/35% Percoll gradient. Cell suspensions were treated with ethidium monoazide under exclusion of light, and washed and irradiated with incandescent light. The cells were incubated for 45 min in 96-well plates (ϳ1 ϫ 10 5 cells at 50 L/well) with freshly prepared H-2L d tetramer and fluorescein isothiocyanate-conjugated anti-CD8 mAb (Becton Dickinson) followed by fixing with 4% formaldehyde, and they were then analyzed by flow cytometry.
Cyst purification. Brains from ME49-infected SwissWebster mice were homogenized in 1% Tween 20 in PBS. The homogenate was passed over a 90%/30% Percoll gradient and centrifuged. The 90%/30% interface and half of the 30% layer were collected and repeatedly washed with PBS.
In vitro intracellular IFN-␥ detection. Splenocytes from Pru-or ME49-infected BALB/c mice were seeded at 4 ϫ 10 6 cells per well and restimulated overnight with 10 g/mL of peptide. Cells were treated for 4 h with 10 g/mL brefeldin A, then labeled with tetramer and anti-CD8 mAb as described above and stained with anti-IFN-␥ mAb by using the BD Cytofix/Cytoperm kit (Becton Dickinson).
Western blot analysis. ME49 tachyzoites, and bradyzoites harvested from mouse brain were lysed in PBS by freezethawing. We then analyzed 0.5, 2, 5 and 10 g of the tachyzoite and bradyzoite lysates by SDS-PAGE. Immunoblot analysis was performed with ROP7 antibodies, GRA4 antibodies, SAG2Y antibodies, or tubulin antibodies at dilutions of 1:1000, 1:2000, 1:2000, and 1:1000, respectively.
RESULTS

Design and validation of conditional ligands for H-2L d class I MHC tetramers.
MHC tetramers enable the direct visualization of antigen-specific T cells [26] , and arrays of MHC tetramers can be produced rapidly by using caged MHC complexes. This technology is based on transient occupation of class I [15] [16] [17] or class II [27] MHC molecules with a conditional ligand. Here, we apply this strategy to the identification of parasitespecific CD8 ϩ T cell epitopes by generating ϳ250 distinct H-2L d MHC tetramers. We designed 3 photocleavable ligands based on the p29 peptide, which conforms to the H-2L d consensus binding motif [28] . After inspection of the crystal structure of H-2L d in complex with p29 ( [29] and figure 1A) we surmised that the Ile, His, and Asn amino acid residues at positions P6, P7, and P8, respectively, could be replaced with the photocleavable 3-amino-3-(2-nitro)phenyl-propanoic acid (Anp) residue. The resulting p29-P6*, p29-P7*, and p29-P8* ligands were synthesized and used for the production of caged H-2L d tetramers.
To validate the peptide exchange reaction, we used 2C T cell receptor (TCR)-transgenic cells that recognize the H-2L d /QL9 complex [30] . Only after UV irradiation in the presence of QL9 did we observe successful peptide exchange for the 3 H-2L d tetramers preloaded with p29-based ligands as visualized by surface staining (figure 1B). Control staining that used an irrelevant H-2L d ligand IPAAAGRFF (see below) established that staining of 2C T cells was strictly peptide-specific. We then applied these conditions to H-2K b complexes carrying photocleavable SV9-P7* [16] . Here, UV-induced peptide exchange yielded reagents that stained both OT-1 and 2C TCR-transgenic cells when provided with the respective SIINFEKL and SIYRYYGL peptide, consistent with the ability of the 2C T cell clone to recognize both allogeneic (H-2L d ) and syngeneic (H-2K b ) peptide-MHC complexes [30] . The p29-P6*, p29-P7*, and p29-P8* photolabile peptides can thus be used as conditional ligands for H-2L d to rapidly generate MHC tetramer arrays of defined specificity in a single step without loss of functional integrity. We arbitrarily chose to use H-2L d /p29-P8* for screening purposes.
Screening for CD8 ؉ T cell epitopes from T. gondii. A type II Pru line engineered to express the model H-2L d antigen ␤-galactosidase, elicits a specific CD8 ϩ T cell response that peaks 3 weeks after infection [31] . We therefore mined the T. gondii database for tachyzoite-stage secreted proteins to compile a partial list of antigens that could be a source of T. gondii CD8 ϩ T cell and table A2 , which are available only as a pdf in the electronic version) out of 33.525 possible nonameric peptides in this protein data set, which we then used to generate distinct H-2L d tetramers. Splenic CD8 ϩ T cells from BALB/c mice were collected 10 and 21 days after intraperitoneal injection of 40 T. gondii ME49 cysts and stained with freshly generated H-2L d tetramers. We found 2 different H-2L d -restricted antigens in these independent screens; the peptide SPMNGGYYM, from GRA4, and IPAAAGRFF, derived from ROP7 ( figure 2C) .
Kinetics of H-2L d tetramer-positive T cells throughout the infection. We found different frequencies and distribution for the GRA4-and ROP7-specific CD8 ϩ T cell response. Infected BALB/c mice exhibited GRA4-reactive T cells as early as 10 days after infection ( figure 2C and 3A) , whereas the ROP7 CD8 ϩ T cell response peaked during week 6 after infection ( figure 3A) . For both epitopes the levels of tetramer-positive CD8 ϩ T cells were 2-3 times higher in the peritoneal cavity (PEC) and brain than in the spleen. The parasite had converted to the bradyzoite stage, since we could detect cysts in fixed brain sections from a BALB/c mouse 4 weeks after infection. (data not shown). Moreover, both epitopes were not only generated in BALB/c mice infected intraperitoneally, but also in animals orally infected with 5 ME49 cysts as evident from the presence of the corresponding tetramer-positive CD8 ϩ T cells (data not shown).
The T. gondii-specific CD8 ϩ T cells displayed up-regulated early activation marker CD69 (figure 3B), compared with uninfected CD8 ϩ T cell populations, as well as in comparison with tetramer-negative CD8 ϩ T cells (data not shown). Surface expression of CD44 (figure 3B) was high, relative to that of the tetramer-negative CD8 ϩ splenocytes, and persisted throughout the later stages of infection, consistent with their in vivo activation state. Upon restimulation in vitro, both the ROP7-and GRA4-specific CD8 ϩ T cells produced IFN-␥ in response to the corresponding peptide ( figure 3C ). Moreover, tetramer-reactive CD8 ϩ T cells from chronically infected animals (week 8 after infection) displayed renewed expression of CD69 on their surface after 12 h of in vivo restimulation with 10 5 T. gondii Pru tachyzoites (data not shown).
Parasites defective in establishing a chronic infection show altered levels of H-2L d /ROP7-positive CD8
؉ T cells. To dissect the origin of the GRA4 and ROP7 antigens in the course of T. gondii infection, we used T. gondii Pru mutants defective in establishing a chronic infection ( [21] and the appendix, which is not available in the print version). BALB/c mice infected with mutant parasites, compared to those infected with wild-type parasites, exhibited a CD8 ϩ T cell response of altered magnitude at 4 and 8 weeks after infection in the brain ( figure 4A ). Animals infected with the Pru mutant 76-E2, which produced fewer and smaller brain cysts (see the appendix and figure 5A, which are Interestingly, the ROP7-CD8 ϩ T cell response was sharply reduced for this 76-E2 mutant, compared with wild-type Pru at 8 weeks after infection, showing the importance of establishing a chronic infection for development of a T cell response against ROP7. The ROP7-CD8 ϩ T cell response peaked early at 4 weeks after infection for the Pru mutant 73F9, which is defective in nuclear trafficking [21] . Even though infection with the 73F9 mutant results in an ϳ200-fold reduction in the number of cysts in the brains of mice, compared with infection with the Pru wild type [21] , microarray analysis showed that 73F9 developed into bradyzoites faster than wild-type Pru in vitro (P. Davis and D. Roos, personal communication). Pru mutant 9xG4, which has a dramatically reduced lethality in IFN-␥ Ϫ/-mice (see the appendix, which is not available in the print version), elicits a reduced CD8 ϩ T cell response for both GRA4 and ROP7 at 8 weeks after infection . Clearly, the kinetics of parasite-stage conversion and the morphology of the bradyzoite stage influence CD8 ϩ T cell specificity. 
The differences seen for the H-2L
d /ROP7-specific T cells prompted us to investigate whether these CD8 ϩ T cells could be detected in BALB/c animals infected with replication-deficient T. gondii 6 weeks after infection. BALB/c mice infected with 2 ϫ 10 6 ␥-irradiated T. gondii Pru tachyzoites failed to elicit an H-2L d /ROP7-specific response in the brain or the spleen (data not shown). We confirmed that all animals were parasiteexposed by checking for serum IgG specific for T. gondii (figure 5B and 5C and figure 6, which are available only in the electronic version). The absence of H-2L d /ROP7 CD8 ϩ T cells in this model can be explained by a requirement of the parasite to present the ROP7 antigenic peptide from the bradyzoite stage to CD8 ϩ T cells. Rhoptries are organelles that secrete their contents during invasion of the tachyzoite stage [34] , and their function during the bradyzoite stage has not been investigated. We therefore examined the expression levels of ROP7 and GRA4 in relation to each other in the tachyzoite and bradyzoite stage of T. gondii. ME49 bradyzoites were prepared from the brains of infected SwissWebster mice and the corresponding ME49 tachyzoites came from serial passage in vitro through fibroblasts (HFFs). GRA4 protein levels were higher during the tachyzoite stage than the bradyzoite stage, whereas expression of ROP7 was comparable between the 2 stages (figure 4B).
DISCUSSION
Even though IFN-␥-producing CD8
ϩ T cells protect mice against toxoplasmic encephalitis [35, 36] , the epitopes that mediate this recognition are unknown. Conventional methods to discover CD8 ϩ T cell epitopes are especially difficult and timeconsuming for parasitic infections and account for this dearth of information. Therefore, we set up a class I MHC tetramer-based screen to directly visualize parasite-specific CD8 ϩ T cells derived from a primary T. gondii infection. We discovered 2 CD8 ϩ T cell 's t test) . B, Western blot analysis of the expression of ROP7 versus GRA4 in T. gondii ME49 tachyzoites and in vivo-generated bradyzoites shows GRA4 to be strongly expressed in the tachyzoite stage only, whereas ROP7 exhibits similar expression profiles in both parasitic stages. SAG2Y is exclusively expressed in bradyzoites, and ␣-tubulin was used as loading control. PE, phycoerythrin. epitopes derived from the T. gondii proteins GRA4 and ROP7. They are unique to GRA4 and ROP7, and neither epitope is polymorphic for the type I (GT1), type II (ME49) or type III (VEG) strains of T. gondii sequenced to date. Together, these common strains account for 90% of the isolates of T. gondii recovered worldwide. Interestingly, the GRA4 protein induces the proliferation of T lymphocytes from infected animals of an H-2 d and H-2 k background [37] . Improvements in protein annotation, secretory protein prediction, and stage-specific microarray transcription, as well as mass spectrometry proteome data, available through the Toxoplasma database, should facilitate further selection of proteins for epitope identification. Relaxation of the search criteria to include peptides of 8 and 10 amino acids may increase the yield of CD8 ϩ T cell epitopes.
GRA4 is a protein secreted through the apicomplexan-specific dense granules (figure 2A) into the parasitophorous vacuole (PV). Here, GRA4 forms a multimeric complex with GRA6 and GRA2 and stably associates with the intravacuolar network [19] . Even though the protein composition of the dense granules within the PV is now known, the function of these proteins is still poorly understood [38] . We found the H-2L d /GRA4 -restricted peptide SPMNGGYYM in the annotation by using the TgTwinScan model, but not with the other annotation algorithms (figure 7, which is available only in the electronic version). Rhoptries are the second organelle released during invasion and some ROP proteins are injected directly into the host cell ( figure  2A ) [33] . ROP7 is a rhoptry bulb protein-a member of the ROP2 kinase family-and is injected into the host cell cytoplasm relocalizing to the PV membrane, possibly interacting with the host cell cytoplasm [18, 39] . The epitope IPAAAGRFF in ROP7 maps to its hydrophobic N-terminal region [40] . Because of the sequence similarity of proteins within the ROP2 family, a sequence related to the IPAAAGRFF epitope with a single amino acid difference is present in 2 other rhoptry proteins-IPAAAL-RFF for both ROP2 and ROP8. However, T cells from T. gondiiinfected mice consistently failed to stain with H-2L d /IPAAAL-RFF tetramers (data not shown).
The frequency of the ROP7-specific CD8 ϩ T cells appears somewhat lower than CD8 ϩ T cells reactive to the secreted model antigen ␤-galactosidase [31] . Whether this implies the presence of other antigens important for the CD8 ϩ T cell response to this stage of the life cycle of T. gondii or is simply the result of an overexpressed model antigen remains open. Of note, the model antigen-specific T cell population was detected only when ␤-galactosidase was expressed under a tachyzoite promoter. The identification of 2 endogenous T. gondii antigens that evoke CD8 ϩ T cell responses with such different kinetics underscores the importance of knowing the true parasitederived epitopes. The prominent GRA4-specific CD8 ϩ immune response during the first 2 weeks after infection, during the T. gondii tachyzoite stage, correlates with the protein expression data (figure 4B). Delivery of the ROP7 antigen during the bradyzoite stage for presentation to CD8 ϩ T cells is a definite possibility, as ROP7 is transcribed (M. Matrajt and D. Roos, personal communication) and, according to our data, expressed in both the tachyzoite and bradyzoite stage (figure 4B). The failure to detect ROP7-specific CD8 ϩ T cells during acute infection might indicate the presence of yet another population of CD8 ϩ T cells that contributes to the early response. Moreover, the secreted protein pool in tachyzoites is large and complex, with other proteins presumably dominating the response. In bradyzoites, the mixture of secreted proteins is less diverse, and the exchange with the host cell is dramatically reduced. ROP proteins are required to assure host cell survival [34] . Because bradyzoites have an extended life span, the ROP proteins might have an as yet underappreciated role in bradyzoites, and if so, they are likely the most abundantly secreted factors.
The pathway for delivery of antigens into the MHC class I presentation pathway for proteins expressed into the parasitophorous vacuole remains elusive [41] . Both GRA4 and ROP7 are transcribed equally in Pru tachyzoites and ME49 cysts, as judged by microarrays (A. Bahl and D. Roos, personal communication). However, we observed altered protein levels for GRA4 in the 2 parasitic stages, and it is tempting to speculate that escape from the PV for GRA4 is differentially regulated during the tachyzoite stage as opposed to the bradyzoite stage. Indeed, GRA4 may be limited or not secreted during the bradyzoite stage and is not part of the cyst wall [42, 43] . ROP7, on the other hand, is most likely associated with the PV membrane, possibly in the host cell cytoplasm [3, 18] . Regardless of the level and timing of expression, ROP7 and GRA4 must access the class I processing machinery. Intracerebral CD8 ϩ T cells infiltrate from the acute phase of T. gondii infection in response to a transgenically expressed tachyzoite-stage antigen; they persist and finally are slowly eliminated by apoptosis [44] . Unknown expression levels and localization of the transgenic antigen chosen may account for the seemingly different behavior we see for the H-2L d /ROP7-specific intracerebral T cells. Selective traffic of antigen-specific CD8 ϩ T cells into the brain occurs in vivo and is dependent on expression of class I MHC by cerebral endothelium and the presence of the cognate antigen [45] . Once in the brain, the CD8 ϩ T cells can undergo additional proliferation [46] . With the identification of 2 stage-specific endogenous T. gondii CD8 ϩ epitopes, these questions now become tractable without the need for genetically engineered parasites [47] .
Underperformance of the immune system causes recrudescence of T. gondii. Continuous surveillance by CD8 ϩ T cells likely keeps T. gondii under control, and candidate CD8 ϩ T cells capable of such surveillance include those that recognize ROP7,
The figure is available in its entirety in the online edition of the Journal of Infectious Diseases. expressed even at the bradyzoite stage. Our results represent the first step toward a more complete characterization of the immune response to T. gondii. The possible identification of epitopes that afford protection against the outgrowth of parasites in cysts may facilitate the development of strategies to vaccinate against or otherwise control this widespread and clinically important pathogen.
